Menu
Home
Forums
New posts
Search forums
What's new
Featured content
New posts
New media
New media comments
New resources
Latest activity
Media
New media
New comments
Search media
Resources
Latest reviews
Search resources
Misc
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Install the app
Install
Home
Forums
Labrish
Nyuuz
Citron's Andrew Left mocks Palantir's hype with a $40 price target
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
[QUOTE="Munyaradzi Mafaro, post: 56884, member: 636"] Citron Research analyst Andrew Left escalated his bearish position against Palantir Technologies by establishing a $40 price target. This valuation represents a potential 77 percent decline from the current trading price of $173.64 per share. Left announced his short position during a Fox Business interview last week. He expanded his negative bet following the company's recent quarterly earnings report. The analyst described his bearish thesis as obvious to market observers. Left based his target price on OpenAI's valuation metrics for comparison purposes. OpenAI trades at approximately 17 times sales based on its $500 billion valuation and $29.6 billion projected 2026 revenue. Applying this multiple to Palantir's consensus 2026 revenue estimate of $5.6 billion yields a theoretical $95.2 billion company valuation. This calculation supports the $40 per share price target. The methodology highlights the disconnect between Palantir's current market valuation and fundamental analysis principles. [/QUOTE]
Insert quotes…
Name
Post reply
Home
Forums
Labrish
Nyuuz
Citron's Andrew Left mocks Palantir's hype with a $40 price target
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
Accept
Learn more…
Top